{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:49:37Z","timestamp":1792154977837,"version":"4.4.0"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Selective estrogen receptor modulators (SERMs) have certain effects on lipid metabolism; however, the results of various studies remain controversial. We conducted a meta-analysis to summarize the existing evidence from cohort studies and randomized controlled trials (RCTs) on the effect of SERM treatment on lipid metabolism in breast cancer patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We conducted a comprehensive search of PubMed, Embase, Cochrane, EBSCO, and the Web of Science databases through January 31, 2026, to identify articles focused on the effects of SERMs on lipid metabolism. Each study included the effect size and 95% confidence interval (95% CI) of the relationship between SERMs and lipid metabolism. Subgroup analyses were also performed to explore potential.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 19 studies (13 RCTs and 6 cohort studies) were included in the meta-analysis. SERMs showed significant differences from other breast cancer treatment methods in terms of total cholesterol (TC) (SMD = \u22120.70; 95% CI: \u22120.91, \u22120.50), triglycerides (TG) (SMD = 0.32; 95% CI: 0.06, 0.59), low-density lipoprotein (LDL-C) (SMD = \u22120.76; 95% CI: \u22121.02, \u22120.50), and the risk of fatty liver occurrence (RR = 1.57; 95% CI: 1.13, 2.18).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>SERMs exhibited significant efficacy in lowering LDL-C and TC; however, they may increase the risk of developing fatty liver. Clinical decision-making should involve a comprehensive evaluation of individual patient characteristics to optimize personalized treatment strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_248_26","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:00:14Z","timestamp":1790766014000},"page":"641-650","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Effects of selective estrogen receptor modulators on lipid metabolism in patients with breast cancer: A systematic review and meta-analysis"],"prefix":"10.4103","volume":"22","author":[{"given":"Qianqian","family":"Wang","sequence":"first","affiliation":[{"name":"School of Public Health, Shandong Second Medical University, Weifang, China"},{"name":"Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute, Jinan, Shandong, China"},{"name":"Center for Big Data Research in Health and Medicine, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Data Open Innovative Application Laboratory, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute, Jinan, Shandong, China"},{"name":"Center for Big Data Research in Health and Medicine, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Data Open Innovative Application Laboratory, Jinan, Shandong, China"},{"name":"School of Nursing and Rehabilitation, Shandong University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongli","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute, Jinan, Shandong, China"},{"name":"Center for Big Data Research in Health and Medicine, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Data Open Innovative Application Laboratory, Jinan, Shandong, China"},{"name":"School of Public Health, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyuan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute, Jinan, Shandong, China"},{"name":"Center for Big Data Research in Health and Medicine, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Data Open Innovative Application Laboratory, Jinan, Shandong, China"},{"name":"School of Public Health, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Lao","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute, Jinan, Shandong, China"},{"name":"Center for Big Data Research in Health and Medicine, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Data Open Innovative Application Laboratory, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute, Jinan, Shandong, China"},{"name":"Center for Big Data Research in Health and Medicine, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Data Open Innovative Application Laboratory, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyong","family":"Ding","sequence":"additional","affiliation":[{"name":"School of Public Health, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute, Jinan, Shandong, China"},{"name":"Center for Big Data Research in Health and Medicine, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Data Open Innovative Application Laboratory, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"R1-20261016","first-page":"229","article-title":"Global cancer statistics 2022: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20261016","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1093\/annonc\/mdz189","article-title":"Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Cardoso","year":"2019","journal-title":"Ann Oncol"},{"key":"R3-20261016","doi-asserted-by":"crossref","first-page":"10753","DOI":"10.3390\/app112210753","article-title":"Existing and emerging breast cancer detection technologies and its challenges: A review","volume":"11","author":"Abdul Halim","year":"2021","journal-title":"Appl Sci"},{"key":"R4-20261016","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast cancer","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"R5-20261016","doi-asserted-by":"crossref","first-page":"230272","DOI":"10.1098\/rsob.230272","article-title":"Oestrogen receptor positive breast cancer and its embedded mechanism: Breast cancer resistance to conventional drugs and related therapies, a review","volume":"14","author":"Yadav","year":"2024","journal-title":"Open Biol"},{"key":"R6-20261016","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1139\/bcb-2015-0007","article-title":"Sensitization of breast cancer cells to doxorubicin via stable cell line generation and overexpression of DFF40","volume":"93","author":"Bagheri","year":"2015","journal-title":"Biochem Cell Biol"},{"key":"R7-20261016","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1186\/s12885-021-08538-5","article-title":"Effects of tamoxifen vs. toremifene on fatty liver development and lipid profiles in breast Cancer","volume":"21","author":"Song","year":"2021","journal-title":"BMC Cancer"},{"key":"R8-20261016","first-page":"7947","article-title":"Comparing heart risk scores to identify the most important risk factors for cardiovascular diseases","volume":"25","author":"Khandia","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R9-20261016","doi-asserted-by":"crossref","first-page":"111871","DOI":"10.1016\/j.biopha.2021.111871","article-title":"Selective estrogen receptor modulators (SERMs) affect cholesterol homeostasis through the master regulators SREBP and LXR","volume":"141","author":"Fern\u00e1ndez-Su\u00e1rez","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"R10-20261016","doi-asserted-by":"crossref","first-page":"759595","DOI":"10.3389\/fonc.2021.759595","article-title":"The effects of endocrine therapies on lipid profiles in Chinese young women with early breast cancer","volume":"11","author":"Kang","year":"2021","journal-title":"Front Oncol"},{"key":"R11-20261016","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00280-017-3491-6","article-title":"Serum lipid and bone metabolism effects of Toremifene vs. Letrozole as adjuvant therapy for postmenopausal early breast cancer patients: Results of a multicenter open randomized study","volume":"81","author":"Shien","year":"2018","journal-title":"Cancer Chemother Pharmacol"},{"key":"R12-20261016","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12944-024-02002-6","article-title":"Lipid changes during endocrine therapy in early-stage breast cancer patients: A real-world study","volume":"23","author":"Li","year":"2024","journal-title":"Lipids Health Dis"},{"key":"R13-20261016","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0021-9150(84)90064-9","article-title":"Serum lipoproteins and proteins after breast cancer surgery and effects of tamoxifen","volume":"52","author":"R\u00f6ssner","year":"1984","journal-title":"Atherosclerosis"},{"key":"R14-20261016","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1200\/JCO.2002.20.4.1026","article-title":"Comparison of the systemic and intratumoral effects of tamoxifen and the aromatase inhibitor vorozole in postmenopausal patients with primary breast cancer","volume":"20","author":"Harper-Wynne","year":"2002","journal-title":"J Clin Oncol"},{"key":"R15-20261016","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R16-20261016","author":"Wells","year":"2021","journal-title":"The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses"},{"key":"R17-20261016","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"R18-20261016","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"R19-20261016","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jrsm.13","article-title":"Critical interpretation of Cochran's Q test depends on power and prior assumptions about heterogeneity","volume":"1","author":"Pereira","year":"2010","journal-title":"Res Synth Methods"},{"key":"R20-20261016","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/1469-0691.12494","article-title":"The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses","volume":"20","author":"Melsen","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"R21-20261016","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1756-185X.2012.01712.x","article-title":"Conducting a meta-analysis: Basics and good practices","volume":"15","author":"Cheung","year":"2012","journal-title":"Int J Rheum Dis"},{"key":"R22-20261016","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"R23-20261016","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/0277-5379(90)90116-B","article-title":"Prevention of breast cancer with tamoxifen \u2013 An update on the Royal Marsden Hospital pilot programme","volume":"26","author":"Powles","year":"1990","journal-title":"Eur J Cancer"},{"key":"R24-20261016","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/bmj.305.6847.225","article-title":"Long term effects of tamoxifen on blood lipid values in breast cancer","volume":"305","author":"Dewar","year":"1992","journal-title":"BMJ"},{"key":"R25-20261016","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10549-005-3783-0","article-title":"The effect of exemestane on the lipidemic profile of postmenopausal early breast cancer patients: Preliminary results of the TEAM Greek sub-study","volume":"93","author":"Markopoulos","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"R26-20261016","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.bjc.6603258","article-title":"Exemestane after tamoxifen as adjuvant hormonal therapy in postmenopausal women with breast cancer: Effects on body composition and lipids","volume":"95","author":"Francini","year":"2006","journal-title":"Br J Cancer"},{"key":"R27-20261016","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ejim.2007.05.016","article-title":"The effects on lipid serum levels of a 2-year adjuvant treatment with exemestane after tamoxifen in postmenopausal women with early breast cancer","volume":"19","author":"Montagnani","year":"2008","journal-title":"Eur J Intern Med"},{"key":"R28-20261016","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/annonc\/mdn545","article-title":"Lipid changes in breast cancer patients on exemestane treatment: Final results of the TEAM Greek substudy","volume":"20","author":"Markopoulos","year":"2009","journal-title":"Ann Oncol"},{"key":"R29-20261016","doi-asserted-by":"crossref","first-page":"860","DOI":"10.7326\/0003-4819-115-11-860","article-title":"Effects of tamoxifen on cardiovascular risk factors in postmenopausal women","volume":"115","author":"Love","year":"1991","journal-title":"Ann Intern Med"},{"key":"R30-20261016","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1093\/jnci\/86.20.1534","article-title":"Effects of tamoxifen on cardiovascular risk factors in postmenopausal women after 5 years of treatment","volume":"86","author":"Love","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"R31-20261016","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/01.ATV.21.2.255","article-title":"Tamoxifen and cardiac risk factors in healthy women: Suggestion of an anti-inflammatory effect","volume":"21","author":"Cushman","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R32-20261016","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/02841860510007585","article-title":"Effect of anastrozole and tamoxifen on lipid metabolism in Japanese postmenopausal women with early breast cancer","volume":"44","author":"Sawada","year":"2005","journal-title":"Acta Oncol"},{"key":"R33-20261016","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s10549-011-1608-x","article-title":"Effects of toremifene and anastrozole on serum lipids and bone metabolism in postmenopausal females with estrogen receptor-positive breast cancer: The results of a 2-year multicenter open randomized study","volume":"128","author":"Anan","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"R34-20261016","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/01.cad.0000215056.47695.92","article-title":"Fatty liver and transaminase changes with adjuvant tamoxifen therapy","volume":"17","author":"Liu","year":"2006","journal-title":"Anticancer Drugs"},{"key":"R35-20261016","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejca.2017.05.002","article-title":"Different patterns in the risk of newly developed fatty liver and lipid changes with tamoxifen versus aromatase inhibitors in postmenopausal women with early breast cancer: A propensity score-matched cohort study","volume":"82","author":"Hong","year":"2017","journal-title":"Eur J Cancer"},{"key":"R36-20261016","first-page":"S189","article-title":"Impact of tamoxifen on development of NAFLD","volume":"13","author":"Lim","year":"2019","journal-title":"Hepatology International"},{"key":"R37-20261016","doi-asserted-by":"crossref","first-page":"e0236506","DOI":"10.1371\/journal.pone.0236506","article-title":"Risk of fatty liver after long-term use of tamoxifen in patients with breast cancer","volume":"15","author":"Yoo","year":"2020","journal-title":"PLoS One"},{"key":"R38-20261016","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1002\/cncr.24374","article-title":"The association of nonalcoholic steatohepatitis and tamoxifen in patients with breast cancer","volume":"115","author":"Saphner","year":"2009","journal-title":"Cancer"},{"key":"R39-20261016","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000358752","article-title":"Adjuvant tamoxifen influences the lipid profile in breast cancer patients","volume":"9","author":"Lin","year":"2014","journal-title":"Breast Care (Basel)"},{"key":"R40-20261016","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2165\/00002512-199608050-00002","article-title":"Tamoxifen in postmenopausal women a safety perspective","volume":"8","author":"Robinson","year":"1996","journal-title":"Drugs Aging"},{"key":"R41-20261016","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/annonc\/mdq707","article-title":"The effect of exemestane, anastrozole, and tamoxifen on lipid profiles in Japanese postmenopausal early breast cancer patients: Final results of National Surgical Adjuvant Study BC 04, the TEAM Japan sub-study","volume":"22","author":"Hozumi","year":"2011","journal-title":"Ann Oncol"},{"key":"R42-20261016","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ecl.2015.09.013","article-title":"Dyslipidemia in special ethnic populations","volume":"45","author":"Pu","year":"2016","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R43-20261016","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2147\/IJGM.S160555","article-title":"Expert opinion on the applicability of dyslipidemia guidelines in Asia and the Middle East","volume":"11","author":"Alshamiri","year":"2018","journal-title":"Int J Gen Med"},{"key":"R44-20261016","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4070\/kcj.2015.45.2.141","article-title":"Effects of age, sex, and menopausal status on blood cholesterol profile in the Korean population","volume":"45","author":"Park","year":"2015","journal-title":"Korean Circ J"},{"key":"R45-20261016","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.breast.2021.07.018","article-title":"Breast cancer survivorship care during the COVID-19 pandemic within an urban New York Hospital System","volume":"59","author":"Mo","year":"2021","journal-title":"Breast"},{"key":"R46-20261016","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.2174\/1871520620666201029114253","article-title":"A bioinformatics study of the involved mechanisms in relapse and drug resistance of tamoxifen-treated breast cancer","volume":"21","author":"Keikha","year":"2021","journal-title":"Anticancer Agents Med Chem"},{"key":"R47-20261016","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1056\/NEJMra022219","article-title":"Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice","volume":"348","author":"Riggs","year":"2003","journal-title":"N Engl J Med"},{"key":"R48-20261016","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/hep.23813","article-title":"Tamoxifen induces triacylglycerol accumulation in the mouse liver by activation of fatty acid synthesis","volume":"52","author":"Cole","year":"2010","journal-title":"Hepatology"},{"key":"R49-20261016","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1124\/jpet.106.114546","article-title":"Tamoxifen inhibits topoisomerases, depletes mitochondrial DNA, and triggers steatosis in mouse liver","volume":"321","author":"Larosche","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"R50-20261016","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1016\/j.jacc.2019.10.009","article-title":"The global burden of cardiovascular diseases and risk factors: 2020 and beyond","volume":"74","author":"Mensah","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R51-20261016","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1161\/CIR.0000000000000743","article-title":"Dietary cholesterol and cardiovascular risk: A science advisory from the American Heart Association","volume":"141","author":"Carson","year":"2020","journal-title":"Circulation"},{"key":"R52-20261016","doi-asserted-by":"crossref","first-page":"e008819","DOI":"10.1161\/JAHA.118.008819","article-title":"Effect of change in total cholesterol levels on cardiovascular disease among young adults","volume":"7","author":"Jeong","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"R53-20261016","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3892\/br.2014.309","article-title":"Triglyceride is strongly associated with nonalcoholic fatty liver disease among markers of hyperlipidemia and diabetes","volume":"2","author":"Tomizawa","year":"2014","journal-title":"Biomed Rep"},{"key":"R54-20261016","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s12328-021-01386-7","article-title":"Pemafibrate, a novel selective PPAR\u03b1 modulator, attenuates tamoxifen-induced fatty liver disease","volume":"14","author":"Tanaka","year":"2021","journal-title":"Clin J Gastroenterol"},{"key":"R55-20261016","doi-asserted-by":"crossref","first-page":"M111.011056","DOI":"10.1074\/mcp.M111.011056","article-title":"Estrogen receptor alpha interacts with mitochondrial protein HADHB and affects beta-oxidation activity","volume":"11","author":"Zhou","year":"2012","journal-title":"Mol Cell Proteomics"},{"key":"R56-20261016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14740338.6.1.1","article-title":"Tamoxifen-induced non-alcoholic steatohepatitis: Where are we now and where are we going?","volume":"6","author":"Osman","year":"2007","journal-title":"Expert Opin Drug Saf"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_248_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:01:36Z","timestamp":1792152096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_248_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_248_26","relation":{},"ISSN":["1998-4138","0973-1482"],"issn-type":[{"value":"1998-4138","type":"print"},{"value":"0973-1482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"2026-02-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}